Clinical Trial Update: Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating soy isoflavones for inner-city infants at risk for asthma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Soy Isoflavones (isoflavones from soy)

Snippet

Sponsor: Rajesh Kumar | Conditions: Wheezing, Asthma in Children | Phase 2 | Status: RECRUITING